Literature DB >> 4940315

The UGDP study.

D S Salsburg.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4940315

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.

Authors:  James J Schlesselman
Journal:  J R Soc Med       Date:  2016-01       Impact factor: 5.344

2.  Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.

Authors:  D Raccah
Journal:  Diabetologia       Date:  2007-03-10       Impact factor: 10.122

3.  Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study.

Authors:  Ulrik M Mogensen; Charlotte Andersson; Emil L Fosbøl; Tina K Schramm; Allan Vaag; Nikolai M Scheller; Christian Torp-Pedersen; Gunnar Gislason; Lars Køber
Journal:  Diabetologia       Date:  2014-09-10       Impact factor: 10.122

4.  One Small Step for Empagliflozin, One Giant Leap for Diabetology.

Authors:  Sanjay Kalra
Journal:  Diabetes Ther       Date:  2015-11-04       Impact factor: 2.945

Review 5.  Cardiovascular outcome trials for anti-diabetes medication: A holy grail of drug development?

Authors:  Mathew John; Ambika Gopalakrishnan Unnikrishnan; Sanjay Kalra; Tiny Nair
Journal:  Indian Heart J       Date:  2016-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.